Streamlining the process of Clinical Trials

The process of clinical trials can be costly to say the least. Clinical affairs consumes an average of 37% of R&D budgets. Despite decades of practice, sponsors continue to underestimate the time required to complete 80% of studies, with the average Phase 1 study running over by 42%, with the average phase 2 study running over 42% and Phase 3 running over 30%. The average Phase 3 study completes over six months behind schedule. Clinproxy, www.clinproxy.com is dedicated to continuing their efforts to reduce these back logs using cutting edge technology and to accelerate patient recruitment through he use of dedicated CRAs and the training of site personnel.